國芳集團(601086.SH):實際控制人張國芳完成減持1%公司股份
格隆匯8月6日丨國芳集團(601086.SH)公佈,公司控股股東、實際控制人張國芳先生於2025年7月28日至2025年8月6日期間,通過集中競價交易方式減持公司股份666萬股,佔公司總股本的1%;本次減持後,張國芳先生當前持有公司股份2.74億股,持股比例41.12%。公司實際控制人一致行動人、董事長張輝陽先生於2025年8月4日至2025年8月6日期間,通過集中競價交易方式減持公司股份298.7萬股,佔公司總股本的0.45%;本次減持後,張輝陽先生當前持有公司股份4005萬股,持股比例6.01%。張國芳先生及張輝陽先生本次減持計劃已實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.